Mastocytosis in childhood

Pediatric Dermatology

Volumn 19, Issue 5, 2002, Pages 375-381

  Heide, Rogier ^a   Tank, Bhupendra ^a   Oranje, Arnold P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHILDHOOD DISEASE; CLINICAL FEATURE; HUMAN; MAST CELL LEUKEMIA; MASTOCYTOMA; MASTOCYTOSIS; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TELANGIECTASIA; URTICARIA PIGMENTOSA; ADOLESCENT; ADULT; CHILD; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFANT; MALE; MAST CELL; NEWBORN; PRESCHOOL CHILD;

STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; MAST CELLS; MASTOCYTOSIS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0036711101     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.2002.00110.x     Document Type: Review

References (50)

1. Soter NA. The skin in mastocytosis. J Invest Dermatol 1991;96:S32-S38; discussion S38-S39.
2. Kettelhut BV, Metcalfe DD. Pediatric mastocytosis. Ann Allergy 1994;73:197-202; quiz 202-207.
3. Metcalfe DD, Akin C. Mastocytosis: Molecular mechanisms and clinical disease heterogeneity. Leuk Res 2001;25:577-582.
4. Buttner C, Henz BM, Welker P, Sepp NT, Grabbe J. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: A possible explanation for divergent clinical behavior. J Invest Dermatol 1998;111:1227-1231.
5. Buttner C, Grabbe J, Haas N, Sepp NT, Kunkel G, Henz BM. Comparison of genetic and immunohistochemical findings in childhood and adult onset urticaria pigmentosa. Int Arch Allergy Immunol 1999;118:206-207.
6. Fodinger M, Mannhalter C. Molecular genetics and development of mast cells: Implications for molecular medicine. Mol Med Today 1997;3:131-137.
7. Valent P, Escribano L, Parwaresch RM, et al. Recent advances in mastocytosis research. Summary Vienna Mastocytosis Meeting 1998. Int Arch Allergy Immunol 1999;120:1-7.
8. Longley BJ, Metcalfe DD. A proposed classification of mastocytosis incorporating molecular genetics. Hematol Oncol Clin N Am 2000;14:697-701, viii.
9. Van Gysel D, Oranje AP. Mastocytosis. In: Harper JL, Oranje AP, Prose NP, eds. Textbook of Pediatric Dermatology. London: Blackwell Science, 2000:600-609.
10. Kettelhut BV, Parker RI, Travis WD, Metcalfe DD. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients. Am J Clin Pathol 1989;91:558-562.
11. Azana JM, Torrelo A, Mediero IG, Zambrano A. Urticaria pigmentosa: A review of 67 pediatric cases. Pediatr Dermatol 1994;11:102-106.
12. Loubeyres S, Leaute-Labreze C, Roul S, Labbe L, Bioulac-Sage P, Taieb A. [Classification and management of mastocytosis in the child]. Ann Dermatol Venereol 1999;126:20-25.
13. Middelkamp MA, Heide R, Tank B, Oranje A. Comparison of mastocytosis arising in childhood and in adults. Eur Acad Derm Venerol 2002;19:379-381.
14. Caplan RM. Urticaria pigmentosa and systemic mastocytosis. JAMA 1965;194:1077-1080.
15. Stein DH. Mastocytosis: A review. Pediatr Dermatol 1986;3:365-375.
16. Oranje AP, Soekanto W, Sukardi A, Vuzevski VD, van der Willigen A, Afiani HM. Diffuse cutaneous mastocytosis mimicking staphylococcal scalded-skin syndrome: Report of three cases. Pediatr Dermatol 1991;8:147-151.
17. Soter NA. Mastocytosis and the skin. Hematol Oncol Clin N Am 2000;14:537-555, vi.
18. Kauhanen P, Kovanen PT, Reunala T, Lassila R. Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation. Thromb Haemost 1998;79:843-847.
19. Kettelhut BV, Metcalfe DD. Plasma histamine concentrations in evaluation of pediatric mastocytosis. J Pediatr 1987;111:419-421.
20. Murphy M, Walsh D, Drumm B, Watson R. Bullous mastocytosis: A fatal outcome. Pediatr Dermatol 1999;16:452-455.
21. Shah PY, Sharma V, Worobec AS, Metcalfe DD, Zwick DC. Congenital bullous mastocytosis with myeloproliferative disorder and c-kit mutation. J Am Acad Dermatol 1998;39:119-121.
22. Teitell M, Rowland JM. Systemic mast cell disease associated with primary ovarian mixed malignant germ cell tumor. Hum Pathol 1998;29:1546-1547.
23. Van Gysel D, Oranje AP, de Vermeiden I, Lijster de Raadt J, Mulder PG, van Toorenenbergen AW. Value of urinary N-methylhistamine measurements in childhood mastocytosis. J Am Acad Dermatol 1996;35:556-558.
24. Roberts LJ II, Oates JA. Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol 1991;96:S19-S24; discussion S24-S25.
25. Horan B. Monitoring and patient safety. Anaesth Intensive Care 1988;16:5-6.
26. Kissling S, Kernland K, Gerbig AW, Hunziker T. Strategies in childhood and adult mastocytosis. Dermatology 1999;198:426-430.
27. Parwaresch MR, Horny HP, Lennert K. Tissue mast cells in health and disease. Pathol Res Pract 1985;179:439-461.
28. Horny HP, Kaiserling E, Parwaresch MR, Lennert K. Lymph node findings in generalized mastocytosis. Histopathology 1992;21:439-446.
29. Schwartz LB, Sakai K, Bradford TR, et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995;96:2702-2710.
30. Horny HP, Sillaber C, Menke D, et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998;22:1132-1140.
31. Agis H, Beil WJ, Bankl HC, et al. Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: Diagnostic role of cell-immunophenotyping. Leuk Lymphoma 1996;22:187-204.
32. Li WV, Kapadia SB, Sonmez-Alpan E, Swerdlow SH. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies. Mod Pathol 1996;9:982-988.
33. Escribano L, Orfao A, Diaz-Agustin B, et al. Indolent systemic mast cell disease in adults: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 1998;91:2731-2736.
34. Escribano L, Orfao A, Villarrubia J, et al. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 1997;30:98-102.
35. Oranje AP. Mastocytosis: Basic aspects, clinical evaluation, and therapy. Pediatr Dermatol 2000;17:75-83.
36. Oranje A, Van Gysel D. Mastocytosis. In: Lorri, Karsambas Amsterdam: Elselvior, ed. European Handbook of Dermatological Treatments. 1999:363-367.
37. Golitz LE, Weston WL, Lane AT. Bullous mastocytosis: Diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme. Pediatr Dermatol 1984;1:288-294.
38. Kettelhut BV, Berkebile C, Bradley D, Metcalfe DD. A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. J Allergy Clin Immunol 1989;83:866-870.
39. Metcalfe DD. The treatment of mastocytosis: An overview. J Invest Dermatol 1991;96:S55-S56; discussion S56-S59.
40. Hirschowitz BI, Groarke JF. Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann Intern Med 1979;90:769-771.
41. Czarnetzki BM, Behrendt H. Urticaria pigmentosa: Clinical picture and response to oral disodium cromoglycate. Br J Dermatol 1981;105:563-567.
42. Businco L, Cantani A, Businco E, Pepys J. Systemic mastocytosis in a 5-year-old child: Successful treatment with disodium cromoglycate. Clin Allergy 1984;14:147-152.
43. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979;301:465-469.
44. Frieri M, Alling DW, Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial. Am J Med 1985;78:9-14.
45. Oranje AP. Atopic dermatitis (AD): Evaluation and therapy. Pediatr Dermatol 2000;17:75-83.
46. Oranje AP, Wolkerstorfer A. Advances in the treatment of atopic dermatitis with special regard to children. Curr Probl Dermatol 1999;28:56-63.
47. Guzzo C, Lavker R, Roberts LJ II, Fox K, Schechter N, Lazarus G. Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Arch Dermatol 1991;127:191-196.
48. Barton J, Lavker RM, Schechter NM, Lazarus GS. Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985;121:1516-1523.
49. Turk J, Oates JA, Roberts LJ II. Intervention with epinephrine in hypotension associated with mastocytosis. J Allergy Clin Immunol 1983;71:189-192.
50. Parris W. Anesthetic management of systemic mastocytosis; experience with 42 cases. Anesth Analg 1986;65:1175-1178.